Vaccines for prevention of human papillomavirus infection
Foerster V, Murtagh J
Record ID 32006000010
The aim of this report is to summarize the available information on use of prophylactic human papillomavirus (HPV) vaccines, particularly: Cervarix (GlaxoSmithKline Biologics) and Gardasil (Merck & Co., Inc.).
Authors' recomendations: Important considerations include vaccine efficacy; acceptability; integration into existing vaccine schedules; cost; role of cervical screening programs; and access, particularly for people in the developing world.
Authors' methods: Overview
Project Status: Completed
URL for project: https://www.ccohta.ca/
Year Published: 2005
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Cancer Vaccines
- Papillomavirus Infections
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.